Viewing Study NCT07001618

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:05 AM

Ignite Modification Date: 2026-03-28 @ 6:23 PM

Study NCT ID: NCT07001618

Status: NOT_YET_RECRUITING

Last Update Posted: 2025-07-23

First Post: 2025-05-23

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module